IN BRIEF: Bird & Bird, Foley Hoag LLP, Goodwin Procter, advised on the matter. Bird & Bird advised SparingVision SAS with a team including Emmanuelle Porte […]
Intellia Therapeutics’ Acquisition of a Stake in SparingVision
Intellia Therapeutics’ Collaboration With Blackstone Life Sciences and Cellex Cell Professionals GmbH
Hogan Lovells represented Intellia Therapeutics on the matter. Intellia Therapeutics launched a new autologous and allogeneic universal chimeric antigen receptor (CAR) T-cell therapy company in a […]
Intellia Therapeutics’ $690 Million Underwritten Public Offering
Goodwin Procter advised Intellia Therapeutics on the deal. Intellia Therapeutics, Inc. (Nasdaq: NTLA) announced its $690 million underwritten public offering on the heels of releasing the first-ever […]